secwatch.observer — SEC 8-K summary
======================================

Issuer:     OMNICELL, INC. (OMCL)
CIK:        0000926326
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0000926326-22-000031
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Omnicell Q3 revenue $348M (+17% YoY); GAAP EPS $0.37; guides Q4 revenue $285M-$295M
--------------------------------------------------------------------------------

- GAAP net income $17M ($0.37/diluted share) vs $29M ($0.61) in Q3 2021.
- Non-GAAP net income $45M ($1.00/diluted share) vs $50M ($1.08) YoY.
- FY 2022 revenue guidance lowered to $1.284B-$1.294B; non-GAAP EPS $2.73-$2.83.
- Q4 revenue forecast $285M-$295M, down sharply from Q3's $348M.
- Cites health system capital freezes and labor shortages as headwinds; plans cost structure adjustments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926326/000092632622000031/0000926326-22-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926326/000092632622000031/omcl-20221102.htm
  HTML page:      https://secwatch.observer/filing/0000926326-22-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer